2018 Florida Controlled Substance Rx Law

As of July 1, 2018, all Florida health care providers who prescribe controlled substances must indicate on the prescription if the Rx is for the treatment of pain other than acute pain, in accordance with HB21 requirements. To accommodate our customers, we have added the required controlled substance Rx law language with checkboxes to all of our Florida prescription pads, including HologramRx pads.

*Please note: Although the law goes into effect on July 1, 2018, controlled substance prescribers that purchased prescription pads prior to the law’s effective date may still use their prescription stock by handwriting the appropriate designation on each prescription sheet for a Schedule II drug.

Please see the excerpts below extracted from the Florida Department of Health regarding this 2018 Rx regulation:

  • The prescriber must indicate “NONACUTE PAIN” on a prescription for an opioid drug listed as Schedule II controlled substance or indicate “ACUTE PAIN EXCEPTION” if the prescription is for the treatment of acute pain with exceptions as specified in section 456.44, Florida Statutes.
  • Health care practitioners are not required to destroy prescription pads already purchased. They can handwrite the words “NONACUTE PAIN” or “ACUTE PAIN EXCEPTION” directly on the prescription pad until they are ready to reorder.

All Florida prescription pads purchased from National Rx Security or ScriptShield have already been brought up to compliance as of May 5, 2018 in preparation for the July 1, 2018 deadline. To purchase your Florida compliant prescription pads, order directly online or Download and Fax in an order form.


Scroll Up